← SynDRA
LY3295668
SynDRA canonical compound SYN1969829 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | AURKA |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- aurora kinase inhibitor
- AURKA INHIBITOR
Cross-references
Synonyms
- (2R,4R)-1-(3-Chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid
- AK-01
- LY-3295668
- (2R,4R)-1-[(3-chloro-2-fluorophenyl)methyl]-4-({3-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyridin-2-yl}methyl)-2-methylpiperidine-4-carboxylic acid
- UNII-1WX8O5XV4R
- 1WX8O5XV4R
- SCHEMBL17747406
- NSC816863
- NSC-816863
- Aurora A kinase inhibitor LY3295668
- HY-114258
- CS-0080775
- LY3295668 (AK-01)
- A16869
- (2R,4R)-1-[(3-Chloro-2-fluoro-phenyl)methyl]-4-[[3-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridyl]methyl]-2-methyl-piperidine-4-carboxylic acid
- 1-((3-Chloro-2-fluorophenyl)methyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyridinyl)methyl)-2-methyl-, (2R,4R)-,4-piperidinecarboxylic acid
- 4-Piperidinecarboxylic acid, 1-((3-chloro-2-fluorophenyl)methyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyridinyl)methyl)-2-methyl-, (2R,4R)-
- EG7
Look up LY3295668 in the interactive SynDRA portal →